MX352192B - Formas de dosificación sólidas que comprenden miel en el recubrimiento. - Google Patents

Formas de dosificación sólidas que comprenden miel en el recubrimiento.

Info

Publication number
MX352192B
MX352192B MX2013008913A MX2013008913A MX352192B MX 352192 B MX352192 B MX 352192B MX 2013008913 A MX2013008913 A MX 2013008913A MX 2013008913 A MX2013008913 A MX 2013008913A MX 352192 B MX352192 B MX 352192B
Authority
MX
Mexico
Prior art keywords
dosage forms
coating
solid dosage
include honey
honey
Prior art date
Application number
MX2013008913A
Other languages
English (en)
Other versions
MX2013008913A (es
Inventor
Edward Stella Mark
Nicole Knights Elissa
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of MX2013008913A publication Critical patent/MX2013008913A/es
Publication of MX352192B publication Critical patent/MX352192B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/288—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A61K35/644—Beeswax; Propolis; Royal jelly; Honey
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893—Tablet coating processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Insects & Arthropods (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Otolaryngology (AREA)
  • Animal Husbandry (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La invención está relacionada a formas de dosificación revestidas de película sólidas que comprenden miel natural en el revestimiento aplicado a esas formas. La miel natural de la forma de dosificación sólida revestida de película tiene un nivel suficiente para ser percibida por el usuario al mismo tiempo que evita que se peguen entre sí o al empaque con el que está en contacto y/o en almacenamiento.
MX2013008913A 2011-02-14 2012-02-13 Formas de dosificación sólidas que comprenden miel en el recubrimiento. MX352192B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161442435P 2011-02-14 2011-02-14
PCT/US2012/024849 WO2012112437A1 (en) 2011-02-14 2012-02-13 Filmcoated solid dosage forms comprising honey in the coating

Publications (2)

Publication Number Publication Date
MX2013008913A MX2013008913A (es) 2014-01-31
MX352192B true MX352192B (es) 2017-11-10

Family

ID=45688302

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2013008913A MX352192B (es) 2011-02-14 2012-02-13 Formas de dosificación sólidas que comprenden miel en el recubrimiento.
MX2017014558A MX357636B (es) 2011-02-14 2012-02-13 Formas de dosificacion solidas que comprenden miel en el recubrimiento.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2017014558A MX357636B (es) 2011-02-14 2012-02-13 Formas de dosificacion solidas que comprenden miel en el recubrimiento.

Country Status (9)

Country Link
US (3) US9421171B2 (es)
EP (1) EP2675437B1 (es)
CN (1) CN103402502A (es)
AU (1) AU2012217908B2 (es)
BR (1) BR112013018941A2 (es)
CA (1) CA2825917C (es)
MX (2) MX352192B (es)
RU (1) RU2605299C2 (es)
WO (1) WO2012112437A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1642125B1 (en) 2003-06-20 2017-09-27 Roche Diabetes Care GmbH Biosensor with multiple electrical functionalities
US8889119B2 (en) * 2007-02-01 2014-11-18 Master Supplements, Inc. Enzyme and prebiotic combinations for enhancing probiotic growth and efficacy
US8568712B2 (en) * 2007-02-01 2013-10-29 Master Supplements, Inc. Enzyme and prebiotic combinations for enhancing probiotic efficacy
US8927253B2 (en) * 2007-02-01 2015-01-06 Master Supplements, Inc. Administration of enzyme and prebiotic combinations that enhance probiotic growth and efficacy
AU2014235034A1 (en) * 2013-03-15 2015-10-01 Buck Institute For Research On Aging Improved cognitive supplements
ES2670619T3 (es) 2013-07-22 2018-05-31 Duchesnay Inc. Composición para la gestión de náuseas y vómitos
US8945539B1 (en) * 2013-11-07 2015-02-03 Master Supplements, Inc. Enzyme and prebiotic combinations for enhancing probiotic efficacy
ITRM20130716A1 (it) * 2013-12-23 2015-06-24 Aboca Spa Societa Agricola Composizione per uso nel trattamento della tosse persistente
US10124954B2 (en) * 2015-01-08 2018-11-13 David G Grossman Infuser coated with a sealant
MX386983B (es) 2016-07-05 2025-03-19 Glaxosmithkline Consumer Healthcare Holdings Us Llc Forma de dosificación oral que contiene un revestimiento exterior de liberación rápida
JP7041120B2 (ja) * 2016-08-04 2022-03-23 ビーピーエスアイ ホールディングス， エルエルシー 飲み込み易い被膜及びそれにより被覆された基材
CN109789101A (zh) * 2016-09-26 2019-05-21 宝洁公司 延长缓解剂型
CN109044984A (zh) * 2018-06-22 2018-12-21 陕西杨凌陕特农业发展有限公司 一种糖衣及其制备方法
US12447130B2 (en) 2019-03-20 2025-10-21 Lyndra Therapeutics, Inc. Capsules and capsule coatings for gastric residence dosage forms
CA3134186A1 (en) 2019-03-20 2020-09-24 Lyndra Therapeutics, Inc. Coatings for gastric residence dosage forms
CN110470806A (zh) * 2019-08-26 2019-11-19 安徽泓顺源生物科技有限公司 一种根据蜂蜜成分辨别蜂蜜真假的方法
EP4132476A1 (en) 2020-04-10 2023-02-15 The Procter & Gamble Company Rheological solid oral composition
US12427092B2 (en) 2020-11-05 2025-09-30 Purosil LLC Device and method for assisting pill swallowing
GR1011108B (el) * 2024-11-27 2026-01-19 Ιουλια Τσετη Συνθεση για την ενισχυση του ανοσοποιητικου συστηματος

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3780185A (en) * 1970-09-30 1973-12-18 Honey Tein Prod Inc Composition of matter including dried honey
US4136163A (en) 1971-02-04 1979-01-23 Wilkinson Sword Limited P-menthane carboxamides having a physiological cooling effect
JPH02207762A (ja) * 1989-02-09 1990-08-17 B K Kk 固形蜂密およびその製造方法
US5348747A (en) * 1992-03-05 1994-09-20 American Home Products Corporation Pharmaceutical coating sugars
US6277409B1 (en) * 2000-02-11 2001-08-21 Mcneil-Ppc, Inc. Protective coating for tablet
CN1668206A (zh) * 2002-09-24 2005-09-14 古木林科有限公司 改进口香糖成分释放的口香糖
CN100582089C (zh) 2003-11-21 2010-01-20 吉万奥丹股份有限公司 N-取代的对-薄荷烷甲酰胺
US20070231387A1 (en) * 2006-04-04 2007-10-04 Luigi Levi Film-coated solid dosage forms
US20080131467A1 (en) * 2006-11-30 2008-06-05 Dennis Nelson Film-coated solid dosage form
US9078824B2 (en) 2007-09-24 2015-07-14 The Procter & Gamble Company Composition and method of stabilized sensitive ingredient
CL2008003230A1 (es) * 2007-11-01 2009-11-27 Sanofi Aventis Healthcare Pty Ltd Composicion de recubrimiento de tableta que comprende polimero celulosico, plastificante, edulcorante y composicion de sabor en polvo la que comprende saborizante asociado con portador solido; fluido de recubrimiento de tableta que comprende dicha composicion; tableta farmaceutica; proceso de preparacion de dicha tableta.
US20090196925A1 (en) * 2008-02-05 2009-08-06 Brady Scott P Natural product coating for tablets
US20090197974A1 (en) * 2008-02-05 2009-08-06 Khaleeq Ahmed Natural dietary supplement tablet
WO2009143841A1 (en) * 2008-05-26 2009-12-03 Fertin Pharma A/S Film-coated compressed chewing gum
RU2399302C2 (ru) * 2008-06-25 2010-09-20 Владимир Борисович Полторацкий Способ получения сыпучего пищевого продукта на основе меда и продукт, полученный по этому способу
EP2346475B2 (en) 2008-11-20 2023-04-19 The Procter & Gamble Company Personal care compositions providing enhanced cooling sensation
WO2010128026A2 (en) 2009-05-05 2010-11-11 Givaudan Sa Organic compounds

Also Published As

Publication number Publication date
EP2675437A1 (en) 2013-12-25
RU2013135509A (ru) 2015-03-27
AU2012217908A1 (en) 2013-08-15
CA2825917A1 (en) 2012-08-23
BR112013018941A2 (pt) 2017-03-21
US9827203B2 (en) 2017-11-28
EP2675437B1 (en) 2018-01-24
US20160331690A1 (en) 2016-11-17
US9351939B2 (en) 2016-05-31
CN103402502A (zh) 2013-11-20
AU2012217908B2 (en) 2016-03-03
RU2605299C2 (ru) 2016-12-20
MX2013008913A (es) 2014-01-31
US20150050416A1 (en) 2015-02-19
CA2825917C (en) 2016-08-30
US9421171B2 (en) 2016-08-23
WO2012112437A1 (en) 2012-08-23
US20120207831A1 (en) 2012-08-16
MX357636B (es) 2018-07-17

Similar Documents

Publication Publication Date Title
MX357636B (es) Formas de dosificacion solidas que comprenden miel en el recubrimiento.
MX355294B (es) Artículos para el cuidado personal que tienen composiciones para el cuidado personal que tienen múltiples zonas amoldables.
WO2014186464A8 (en) Stabilized humicola lanuginosa lipase variants in water-soluble films
CL2013001602A1 (es) Metodo para reducir o inhibir la progresion del nivel de fatiga en pacientes con esclerosis multiple y para proporcionarles neuroproteccion que comprende administrar oralmente laquinimod o una sal del mismo; laquinimod para reducir el nivel de fatiga, mejorar el estado funcional y entregar neuroproteccion en esclerosis multiple.
EP2803706A4 (en) HARD COATING COMPOSITION AND JEWELERY FILM WITH REDUCED AVAILABILITY THEREFOR
CL2015002181A1 (es) Tratamiento de formas progresivas de esclerosis múltiple con laquinimod.
DOP2020000031A (es) Comprimidos que tienen aceptación mejorada y buena estabilidad durante el almacenamiento
CL2016001546A1 (es) Composición para el cuidado oral que comprende serina y al menos una sal de zinc.
AR082215A1 (es) Composicion farmaceutica agradable al paladar
IL230264B (en) yarmulka
CL2016000179A1 (es) Formulación de combinación que contiene metformina de liberación prolongada e inhibidor de la hmg-coa reductasa de liberación inmediata.
MX2015017347A (es) Miembro estampado en caliente y método para la fabricación del mismo.
CN302436038S (zh) 胶带分配器
TWD144892S1 (zh) 容器
CN302220956S (zh) 胶带分配器
CN302002503S (zh) 嵌入式间接反射型灯具
CN302333696S (zh) 胶带分配器
CN302230098S (zh) 牙刷包装套
CN302373162S (zh) 胶带分配器
CN302243255S (zh) 胶带分配器
CN302111386S (zh) 胶带分配器
CN301923100S (zh) 电梯用显示器
CN302436516S (zh) 无旋涡水泵控制阀
CN302045038S (zh) 皂液泵
AR083605A1 (es) Recipiente para el cuidado personal

Legal Events

Date Code Title Description
FG Grant or registration